Paydirt
KALV
Ticker

KalVista Pharmaceuticals, Inc.

KALV

KALV has 8 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 0 purchases and 8 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed May 27 and filed May 29. The most active filer was Benjamin L Palleiko with 12 filings.

Add to watchlist
Filings, ttm
8
0 buys · 8 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$5.5M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
May 27
Filed May 29
ADViAverage daily dollar volume
–
not on file
Share price · 12M
$27.00 (+0.0%)
$28.00$27.50$27.00Jun 11Jun 12

Adjusted for splits and dividends.

Volume by month
$3.7M$1.9M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $133KFeb 2025 · buys $3.0MApr 2025 · buys $236KMay 2025 · sells $119KJun 2025 · sells $104KJul 2025 · sells $992KAug 2025 · sells $145KSep 2025 · sells $116KNov 2025 · sells $147KDec 2025 · sells $120KFeb 2026 · sells $156KMar 2026 · sells $3.7MApr 2026 · sells $193KMay 2026 · sells $1.2M
Buys $3.3M Sells $7.2M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
BP Benjamin L Palleiko CHIEF EXECUTIVE OFFICER 12 filings VP Venrock Healthcare Capital Partners EG, L.P. 10% owner 2 filings CY Christopher Yea CHIEF DEVELOPMENT OFFICER 2 filings VL VHCP Management EG, LLC 10% owner 1 filing VL VHCP Management III, LLC 10% owner 1 filing VP Venrock Healthcare Capital Partners III, L.P. 10% owner 1 filing
Recent filings
Christopher YeaSALE CHIEF DEVELOPMENT OFFICER $905K
33,800 sh × $26.78
Exec May 27
Filed May 29 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $293K
10,926 sh × $26.78
Exec May 22
Filed May 26 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $193K
9,550 sh × $20.22
Exec Apr 17
Filed Apr 20 · 5:30 PM ET Venrock Healthcare Capital Partners EG, L.P.SALE 10% owner $3.6M
211,288 sh across 3 lots
Exec Mar 25
Filed Mar 27 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $108K
6,693 sh × $16.08
Exec Mar 9
Filed Mar 10 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $156K
10,034 sh × $15.57
Exec Feb 23
Filed Feb 24 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $120K
7,294 sh × $16.51
Exec Dec 8 2025
Filed Dec 9 2025 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $147K
10,940 sh × $13.45
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $116K
7,294 sh × $15.84
Exec Sep 8 2025
Filed Sep 9 2025 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $145K
10,940 sh × $13.22
Exec Aug 22 2025
Filed Aug 25 2025 · 5:30 PM ET Christopher YeaSALE CHIEF DEVELOPMENT OFFICER $475K
30,250 sh × $15.69
Exec Jul 9 2025
Filed Jul 10 2025 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $517K
32,979 sh × $15.69
Exec Jul 9 2025
Filed Jul 10 2025 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $104K
7,169 sh × $14.50
Exec Jun 9 2025
Filed Jun 10 2025 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $119K
9,999 sh × $11.88
Exec May 22 2025
Filed May 23 2025 · 5:30 PM ET Venrock Healthcare Capital Partners EG, L.P.PURCHASE 10% owner $236K
25,000 sh × $9.42
Exec Apr 9 2025
Filed Apr 11 2025 · 5:30 PM ET VHCP Management EG, LLCPURCHASE 10% owner $1.5M
161,700 sh across 2 lots
Exec Feb 12 2025
Filed Feb 14 2025 · 5:30 PM ET Venrock Healthcare Capital Partners III, L.P.PURCHASE 10% owner $929K
100,352 sh across 2 lots
Exec Feb 7 2025
Filed Feb 11 2025 · 5:30 PM ET VHCP Management III, LLCPURCHASE 10% owner $622K
70,023 sh across 3 lots
Exec Jan 30 2025
Filed Feb 3 2025 · 5:30 PM ET Benjamin L PalleikoSALE CHIEF EXECUTIVE OFFICER $133K
14,400 sh × $9.26
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET